COPD News Today Home | COPD News Today
Sep 18, 2024 · COPD is a chronic inflammatory disease of the lungs, in which the airways become blocked, causing cough with mucus, wheezing, and shortness of breath.
New Advances in Managing COPD | TIME
Mar 18, 2024 · From innovative new lung valves to refinements in the deployment of inhaled therapies and vaccines, the landscape of COPD care and treatment is changing.
A New COPD Treatment is FDA Approved
Jul 8, 2024 · On June 26, 2024, Verona Pharmaceuticals announced that its new medication, Ensifentrine (Ohtuvayre), was approved by the U.S. Food and Drug Administration (FDA) for the maintenance treatment of Chronic Obstructive Pulmonary Disease (COPD). See …
Ohtuvayre effective across key patient subgroups: ENHANCE trials
4 days ago · Ohtuvaryre was superior to the placebo at easing COPD symptoms, including dyspnea, regardless of bronchitis history, with differences reaching statistical significance at nearly all time points. The treatment also tended to be associated with greater life quality gains.
COPD News - ScienceDaily
4 days ago · Latest research news on COPD, including chronic bronchitis, chronic obstructive airway disease, chronic obstructive lung disease and emphysema.
FDA approves new COPD drug developed by firm in Raleigh. First …
Jun 27, 2024 · A new COPD drug, developed by Verona Pharma, was approved by the FDA Wednesday. The drug, ensifentrine, is the first new type of maintenance treatment for COPD in over a decade.
Dupixent as New Treatment for COPD - HealthCentral
Sep 27, 2024 · For people with this progressive and incurable disease, that’s exciting news. Dupixent is the first newly approved treatment for COPD in more than a decade.
Dupixent eases flares, aids lung function with COPD: NOTUS trial
Jun 17, 2024 · Dupixent (dupilumab) as an add-on maintenance treatment significantly eased exacerbations and lung symptom severity while improving lung function and quality of life — among people with moderate to severe chronic obstructive pulmonary disease (COPD).
Immune treatment tackles chronic obstructive pulmonary disease
Aug 16, 2023 · Chronic obstructive pulmonary disease (COPD) is a common lung disease caused by tobacco smoke and other airborne pollutants, and it can be fatal.
GOLD COPD report: 2023 update - The Lancet Respiratory Medicine
On Nov 14, 2022, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) published their 2023 global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (COPD).